Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website
FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule
(Logo Graphic) Office of In Vitro Diagnostic Device Evaluation and Safety OIVD


Search OIVD
 
(Powered by Google)
(navigation menu)
  • All OIVD Products
  • 510(k) Database
  • PMA Database
  • CLIA Database
  • Home use/OTC tests
  • IVD Guidances
  • IVD Standards
  • CeSub Turbo 510(k)
     eSubmissions
(navigation menu)
Home Regulatory Assistance Home & Lab Tests About Us Other Resources Contact Us

Welcome to the Office of In Vitro
Diagnostic Device (OIVD) Evaluation and Safety Web Site

Subscribe Receive OIVD Updates by Email

Regulatory Assistance
* New CeSub Turbo 510(k)
eSubmissions
* New Suggested Analytical Testing
Protocol For IVD Devices Manufactured
With Contaminated Heparin
* Code of Federal Regulations (CFR)
  Overview of IVD Regulation
  Guidance Documents
  IVD Standards
  FDA Advisory Committees
  Device Advice
  Medical Device User Fees (MDUFMA)
  Manufacturer Certification Programs
  Enforcement Letters to Industry
  Find a Predicate Device
  Decision Summaries
  Find Device CLIA '88 Categorization
  Indications for Use Form
  Health Hazard Evaluation Form
Home and Lab Tests
 

New Reporting Glucose Device Problems

 

Rapid Lead Screening Test

* Glossary of Terms
  Home-Use Tests
 

Lab Tests

  Safety Tips for Laboratorians
  New LabNet News
  Recalls
  Find All FDA-Approved Home & Lab Tests
About Us
  Office Information
  Mission
  Expertise
  Organizational Structure
  Phone and Email List
  Employment Opportunities
  Calendar of Events
  Meetings & Presentations
  OIVD Annual Reports
 
In Vitro Device News
(Updated Jan. 16, 2009)
FDA Publishes a New Guidance Document on Assay Migration Studies for IVDs
FDA Issued a Warning Letter to the CEO of LabCorp Regarding The Illegal Marketing of The OvaSure™ Test
FDA Clears New CDC Test to Detect Human Influenza
FDA invites the CEO of LabCorp to discuss strategies for clinical validation of the OvaSure™ Test.
  More OIVD News

Updated January 16, 2009

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH